InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Dougherty Michael Philip. Director active across 1 company, notably bioAffinity Technologies, Inc.. Cumulatively, 2 reports have been published. Activity tracked since 6 June 2023. The latest transaction was disclosed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条